Neurol. praxi. 2014;15(6):338-340

Treating late stage Parkinson's disease with continuous Duodopa administration

MUDr. Václav Dostál1, doc. MUDr. Edvard Ehler, CSc.1, MUDr. Petr Vyhnálek, Ph.D.2
1 Neurologická klinika PKN a.s., Pardubice
2 Interní klinika PKN a.s., Pardubice

We report a case of a 63-year-old patient in late stage Parkinson's disease in whom compensation of late motor complications could no longer be achieved with oral treatment. Following the insertion of a PEG tube and intrajejunal administration of the Duodopa gel, the patient's condition improved significantly, with substantial regression of the 'off' states and alleviation of hyperkinesia.

Keywords: late stage Parkinson's disease, motor complications, fluctuations of ability to move and dyskinesia, Duodopa

Published: December 20, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dostál V, Ehler E, Vyhnálek P. Treating late stage Parkinson's disease with continuous Duodopa administration. Neurol. praxi. 2014;15(6):338-340.
Download citation

References

  1. Bareš M. Pozdní hybné komplikace Parkinsonovy nemoci - wearing off a další motorické fluktuace. Neurol. praxi, 2008; 9(2): 96-99.
  2. Jenner P. Preventing and controlling dyskinesia in Parkinsons disease - a view of current knowledge and future opportunities. Mov Disord 2008; 23(Suppl 3): 585-598. Go to original source... Go to PubMed...
  3. Kianička B, Žák J, Bareš M. Využití perkutánní endoskopické gastrostomie - přehled indikací, popis techniky a současné trendy v neurologii. Cesk Slov Neurol N2012; 75: 165-169.
  4. Nyhoml D. Enteral levodopa/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinsons disease. Expert Rev Neurother. 2006; 6(10): 1403-1411. Go to original source... Go to PubMed...
  5. Olanow CW, Agid Q, Mizuno Y, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F. Levodopa in the treatment of PD. Mov Disord 2004; 19: 997-1003. Go to original source... Go to PubMed...
  6. Roth J, Havránková P. Vztah motorických a non-motorických symptomů Parkinsonovy nemoci k dopaminergní terapii, část první. Neurol. praxi, 2008; 9(1): 33-36.
  7. Růžička E, Roth J, Kaňovský P, Sekyrová M, Urgošík D, Vladyka V. Parkinsonova nemoc a parkinsonské syndromy, Galen, 2000.
  8. Zibetti M, Merola A, Artusi CA, Rizzi L, Angrisano S, Reggio D, De Angelis C, Rizzone M, Lopiano L. Levodopa/ carbidopa intestinal gen infusion in advanced Parkinsons disease: a 7-year experience. Eur J Neurol. 2014; 21(2): 312-318. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.